Concepedia

BaoChau Le

BL

Statistics

Publications

6

Citations

1K

H-Index

6

Active since

2012

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

BaoChau Le is an author at GlaxoSmithKline (United States) specializing in molecular biology, molecular oncology, and epigenetic regulation in cancer.

Publications per year

2012–2018

6

Publications

6

Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing

Sarah V. Gerhart, Wendy A. Kellner, Christine Thompson et al. · Scientific Reports · 2018 · 208 citations · Full text

, , +13

BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models

Anastasia Wyce, Gopinath Ganji, Kimberly N. Smitheman et al. · PLoS ONE · 2013 · 204 citations · Full text

, , +17

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762

Aristeidis Chaidos, Valentina S. Caputo, Katerina Gouvedenou et al. · Blood · 2013 · 202 citations

, , +6

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

Anastasia Wyce, Yan Degenhardt, Yuchen Bai et al. · Oncotarget · 2013 · 177 citations · Full text

, , +17

Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation

Glenn S. Van Aller, Nicolas Reynoird, Olena Barbash et al. · Epigenetics · 2012 · 174 citations · Full text

, , +17

1–5 of 6